semaglutide glucagon Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is an increasingly popular medication for improving glycemic control and promoting weight loss in patients with type 2 diabetes or obesity. Although gastrointestinal symptoms glp 1 nejm Semaglutide, a

[6] Their decision to prefer Wegovy means easier access for many patients seeking GLP-1 coverage

Pregnancy testing should be performed when applicable, and patients who could become pregnant should be counseled on contraception during treatment

Recent postmarketing data (reports from people whove used the medication since it became available for use) has also identified more serious complications , including ileus (a type of intestinal blockage) and severe constipation leading to fecal impaction

As you embark on this journey, know that together, we can achieve your goals

Most patients notice reduced appetite within the first few days and may lose 3 to 5 pounds in the first week, much of which is water weight